back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-13 16:23 Tx date 2023-10-21 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-7,500 vol |
46,251 | |
| Filed 2024-01-13 15:56 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,267
+13,334 vol $1.07 each |
185,136 | |
| Filed 2024-01-13 15:55 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-14,267.38
-13,334 vol $1.07 each |
1,666 | |
| Filed 2023-11-18 15:14 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,733
+1,667 vol $1.04 each |
171,802 | |
| Filed 2023-11-18 15:14 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,733.68
-1,667 vol $1.04 each |
15,000 | |
| Filed 2023-09-15 18:15 Tx date 2023-09-12 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
53,751 | |
| Filed 2023-01-14 15:50 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,866
+13,333 vol $0.59 each |
170,135 | |
| Filed 2023-01-14 15:49 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-7,866.47
-13,333 vol $0.59 each |
16,667 | |
| Filed 2022-12-01 22:08 Tx date 2022-11-28 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,560
+5,334 vol $0.48 each |
156,802 | |
| Filed 2022-12-01 22:07 Tx date 2022-11-28 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-2,560.32
-5,334 vol $0.48 each |
30,000 | |
| Filed 2022-11-19 12:41 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$800.16
+1,667 vol $0.48 each |
151,468 | |
| Filed 2022-11-19 12:41 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-800.16
-1,667 vol $0.48 each |
35,334 | |
| Filed 2022-11-19 12:38 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000 vol |
38,751 | |
| Filed 2022-01-13 13:50 Tx date 2022-01-11 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+13,333 vol |
149,801 | |
| Filed 2022-01-13 13:49 Tx date 2022-01-11 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-13,333 vol |
37,001 | |
| Filed 2021-12-01 23:35 Tx date 2021-11-29 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,333 vol |
136,468 | |
| Filed 2021-12-01 23:34 Tx date 2021-11-29 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,333 vol |
50,334 | |
| Filed 2021-11-19 20:19 Tx date 2021-11-15 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,000 vol |
55,667 | |
| Filed 2021-10-13 17:14 Tx date 2021-10-04 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,000 vol |
131,135 | |
| Filed 2021-10-13 17:13 Tx date 2021-10-04 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-12,000 vol |
50,667 | |
| Filed 2021-06-06 16:22 Tx date 2021-06-02 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$306,889
+69,377 vol $4.42 each |
119,135 | |
| Filed 2021-02-27 16:49 Tx date 2021-02-23 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$71,296
+11,175 vol $6.38 each |
49,758 | |
| Filed 2021-01-15 17:48 Tx date 2021-01-11 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+40,000 vol |
62,667 | |
| Filed 2020-12-17 18:12 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-204,000 vol |
22,667 | |
| Filed 2020-12-17 18:11 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-303,757 vol |
33,751 | |
| Filed 2020-12-17 18:10 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-347,242 vol |
38,583 | |
| Filed 2020-12-17 14:42 Tx date 2020-11-30 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+53,333 vol |
385,825 | |
| Filed 2020-12-17 14:41 Tx date 2020-11-30 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-53,333 vol |
226,667 | |
| Filed 2020-10-08 22:32 Tx date 2020-10-05 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+120,000 vol |
332,492 | |
| Filed 2020-10-08 22:31 Tx date 2020-10-05 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-120,000 vol |
280,000 | |
| Filed 2020-06-06 14:30 Tx date 2020-06-01 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-91,500
-150,000 vol $0.61 each |
212,492 | |
| Filed 2020-06-06 14:29 Tx date 2020-06-01 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$49,500
+150,000 vol $0.33 each |
362,492 | |
| Filed 2020-06-06 14:28 Tx date 2020-06-01 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-49,500
-150,000 vol $0.33 each |
337,508 | |
| Filed 2019-11-28 13:06 Tx date 2019-11-28 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+160,000 vol |
400,000 | |
| Filed 2019-10-29 12:07 Tx date 2019-10-24 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,400
-120,000 vol $0.445 each |
212,492 | |
| Filed 2019-10-10 15:53 Tx date 2019-10-03 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+120,000 vol |
332,492 | |
| Filed 2019-10-10 15:50 Tx date 2019-10-03 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-120,000 vol |
240,000 | |
| Filed 2018-10-05 Tx date 2013-06-10 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-05 Tx date 2018-10-03 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
97 - Other
|
+360,000 vol |
360,000 | |
| Filed 2018-04-20 Tx date 2018-04-19 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$27,186
+187,492 vol $0.145 each |
212,492 | |
| Filed 2018-04-20 Tx date 2018-04-19 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-27,186.34
-187,492 vol $0.145 each |
487,508 | |
| Filed 2017-04-03 Tx date 2017-03-31 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
675,000 | |
| Filed 2016-03-11 Tx date 2016-03-09 |
$ATE
Antibe Therapeutics Inc. |
Flower, Roderick John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,250
+250,000 vol $0.145 each |
475,000 |